This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Lilly, Boehringer Ingelheim in duloxetine co-promotion
22 Aug 2006
Boehringer Ingelheim and Eli Lilly will co-promote worldwide (excluding Japan) duloxetine for female stress urinary incontinence (SUI); the partners will also co-promote Lilly's depression drug duloxetine HCl under the brand name Cymbalta worldwide outside the US--where Lilly already has a co-promotion agreement with Quintiles division Innovex--and excluding Japan.
R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?